Promoting Excellence in Education, Research,
and Patient Care in the Rapidly Evolving
Management of Gastrointestinal Cancer
International Society of
Gastrointestinal Oncology
isgioEstablished 2003

2010 Gastrointestinal Oncology Conference Review

2010 Gastrointestinal Oncology Conference
September 23-25, 2010

Please click on abstract title to review abstract PDF file (opens in a new window).

Esophageal Cancer
  Thrombosis and Cancer
Gary H. Lyman
Duke University and the Duke Comprehensive Cancer Center, Durham, NC

Palliative Stenting With or Without Radiotherapy for Inoperable Esophageal Cancer: A Randomized Trial
Amit Javed
Duke University and the Duke Comprehensive Cancer Center, Durham, NC

Pancreatic Cancer

Neuroendocrine Tumors of the Pancreas: An Update
Matthew Kulke
Dana-Farber Cancer Institute, Boston, MA

  Risk of Metastatic Spread in Patients with Early-Stage, Surgically Resected Pancreatic Neuroendocrine Tumors
Jonathan Strosberg, Asima Cheema, Jill Weber, Domenico Coppola, Larry Kvols
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
  Incidental Diagnosis of Pancreatic Neuroendocrine Tumors
Asima Cheema
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
  A Placebo-Controlled, Randomized Phase II Study of Conatumumab (C) or AMG 479 (A) or Placebo (P) + Gemcitabine (G) in Patients With Metastatic Pancreatic Cancer (mPC)
Howard Safran
Brown University Oncology Group, Providence, RI
Advanced Colorectal Cancer

Curable Metastatic Colorectal Cancer
Jean-Nicolas Vauthey
The University of Texas M.D. Anderson Cancer Center, Houston, TX


Survival of Colorectal Cancer Patients in Iran
Mohammad Esmaeil Akbari
Cancer Research Center, Shahid Beheshti University of Medical sciences, Tehran, Iran


Chemotherapy with Vinorelbine-Tartrate Induces Chemoresistant Cancer Stem Cell (CSCs) Renewal in Colorectal Cancer (CRC) by the Square to Sickle Shift Causing Metastasis
John Giannios
Head of Translational Oncology, Erasinio Oncology Hospital, Athens, Greece

Hepatobiliary Cancer

Hepatocellular Carcinoma in the West
Andrew X. Zhu
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA

  Chemotherapy Outcomes for the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: A Retrospective Analysis
Karen R. Eckmann
Departments of Pharmacy, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Adjuvant Colon Cancer

Inherited Syndromes in Gastrointestinal Cancers
Henry T. Lynch
Creighton University School of Medicine, Omaha NE

Gastric Cancer
  Combination Chemotherapy With Docetaxel, Cisplatin and S-1 (DCS) for Advanced Gastric Cancer
Wasaburo Koizumi
Kitasato University School of Medicine, Sagamihara-City, Kanagawa, Japan
  Intensity Modulated Radiation Therapy (IMRT) With Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma
Twisha Chakravarty
Department of Radiation Oncology, U.T. M.D. Anderson Cancer Center, Houston, TX
  HER2 Status and Response to Adjuvant Chemotherapy in Resectable Gastric Cancer
Zoran Petrovic
Department of GI Oncology, Clinic of Gastroenterology, VMA, Belgrade, Serbia
Rectal Cancer
  Chemoradiotherapy in Rectal Cancer: Clinical Do's and Don'ts
Christopher H. Crane
M.D. Anderson Cancer Center, Houston, TX

Expression of PTEN During Preoperative Radiotherapy Combined With Capecitabine Chemotherapy in Chinese Patients With Locally Advanced Rectal Cancer
Daoyuan Wang
Department of Medical Oncology, The First Affiliated Hospitla to Guangzhou Medical College, Guangzhou, China

Abstracts Selected for Poster Presentations
(note presenting authors appear in bold)
Esophageal Cancer
  Esophageal Cancer: Retrospective Review of a Small-Volume, Single-Institution Experience in the Past Twelve Year Period
Hong W. Chin
Dayton VA Medical Center and Wright State University, Dayton, OH
  Proximal Extent of Spread in Squamous Cell Carcinoma of the Esophagus
A. Prabhakaran, S. Ilango, U.P. Srinivasan, Benet Duraisamy, S. Karthikeyan, J. Chandrasekar, M. Kanagavel, T. Selvaraj, A. Amudhan, R. Prabhakaran,
S.M. Chandramohan
Madras Medical College, Government General Hospital, Chennai, India
  Management and Outcome of Intrathoracic Bleeding Due to Vascular Injury During Transhiatal Esophagectomy
Amit Javed, Sujoy Pal, Peush Sahni, Tushar Kanti Chattopadhyay
All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
Pancreatic Cancer
  Antitumor Effects of Low Molecular Weight Heparin in Patients With Advanced Pancreatic Cancer
Peter YZ Jiang, Jerry P. Jiang, Linda Whittaker, James E. Congdon, Xiaowen Wang, Elie P. Saikely, Luke N. Walker
Providence Regional Cancer Partnership, Everett, WA
  Long-Term Outcome of High Intensity Focused Ultrasound Treatment (HIFU) in Advanced Pancreatic Cancer
Mun Kyung Jung, Hye Young Sung, Se Hyun Cho, Joon-Yeol Han, Seung Eun Jung, Sung Tai Han, In-Sik Chung
Seoul Saint Mary's Hospital, College of Medicine, The Catholic University of Korea, Kyunggi-do, South Korea
  Prognostic Relevance of a Novel AJCC Staging Classification for Neuroendocrine Tumors of the Pancreas
Jonathan Strosberg, Asima Cheema, Jill Weber, Domenico Coppola, Larry Kvols
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
  Protein Kinase D1 Promotes Cell Proliferation and Invasion of Human Pancreatic Cancer Cells
S. Tanasanvimon, N. Ochi, Y. Matsuo, Z. Tong, S. Guha
Department of Gastroenterology, Hepatology, and Nutrition, The UT MD Anderson Cancer Center, Houston, Texas
Advanced Colorectal Cancer
  The Pattern and Prevention of Colorectal Cancer in Sudan
Abdelrahim MI, Suliman SH, Salim OH, Ibrahim SZ, El Tahir MA, Mudawi HM, Dabora A, Abbas S,
Yousif DO, Ahmed KM.
Soba Gastroenterology Research Unit, Khartoum, Sudan
  Colorectal Cancer Prevalence According to Survival Data in Iran: 2007
Farzaneh Esna-Ashari, Mohammad Reza Sohrabi, Alireza Abadi, Abas Ali Mehrabian, Bahram Mofid, Mehrdad Bohluli, Mohammad Esmaeil Akbari
Shahid Beheshti University of Medical Sciences, Tehran, Iran
  Colorectal Cancer Population: The Role of Screening
Esther Uña Cidón
Department of Clinical Oncology, Clinical University Hospital of Valladolid (Spain)
  Systemic Chemotherapy With Cextuximab Plus CAPIRI for Patients With Liver Metastases From Colorectal Cancer
Z. Petrovic, D. Tarabar, I. Tufegdzic, B. Milekic, R. Doder
Dept. of GI Oncology, Clinic of gastroenterology, VMA, Belgrade, Serbia
Hepatobiliary Cancer
  Improved Outcomes in Patients with Hepatitis-C-Related Hepatocellular Carcinoma Treated with Interferon-based Antiviral Therapy Following Liver Transplantation
Ashish Singhal, Shi-Feng Li, Lenzi Elliott, Clay Gates, Sajid Jalil, Vivek Kohli
Nazih Zuhdi Transplant Institute, INTEGRIS Baptist Medical Center, Oklahoma City, OK
  Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization for Metastatic Neuroendocrine Tumors
Jonathan Strosberg, Asima Cheema, Tiffany Campos, Tiffany Valone, Larry Kvols
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Adjuvant Colon Cancer
  Complete Response of HER-2/neu Amplified, Metastatic, Heavily Treated Colon Cancer to Dual HER-2/neu Inhibitory Therapy
Syed Mustafa Karim, Mark Katlic, Rodrigo Erlich
Geisinger/Fox Chase Cancer Center, Wilkes Barre, PA
Gastric Cancer
  Tesataxel, a Novel Oral Taxane: Comparison of Once-Every-Three-Weeks versus Once-Weekly x 3 Weeks Dosing Schedule
M. Beeram, A. Patnaik, K. Papadopoulos, A. Qureshi, A. W. Tolcher
South Texas Accelerated Research Therapeutics (START), San Antonio, TX; Genta Incorporated, Berkeley Heights, NJ
  Analysis of Two Methods of Dye Injection for the Study of Sentinel Node Lymphatic Mapping in Gastric Cancer
S. Ilango, A. Prabhakaran, U.P. Srinivasan, A. Benet Duraisamy, S. Karthikeyan, J. Chandrasekar, M. Kanagavel, R. Prabhakaran, A. Amudhan, T. Selvaraj, S.M. Chandramohan
Madras Medical College, Government General Hospital, Chennai, India
  Chemotherapy-Induced Angiogenesis, and Metastatic Spread With Cytostatic Vinorelbine-Tartrate in Advanced Gastrointestinal Stromal Tumors (GIST) Was Circumvented With Induced Pluripotent Stem Cells (iPSCs) Encoded With Anti-GRP78 shRNA, Which Induces Apoptosis After a Gene Silencing Bystander Effect (GSBE)
John Giannios, John Papanikolaou
Erasinio Oncology Hospital, Athens, Greece
  Does the Non-Lifting Sign Predict the Depth of Invasion in Early Gastric Cancer?
Beom Jin Kim, Jae J. Kim, Sang-Jung Kim, Kyung Mee Kim, Chul Keun Park
Chung-Ang University College of Medicine, Seoul, Korea
Samsung Medical Center Sungkyunkwan University of Medicine, Seoul, Korea
Boondang Jaesaeng General Hospital, Gyunki-do, Korea
  DNA Mismatch Repair Proteins (MLH1, MSH2, PMS2 and MSH6) Expression in Early-Onset Gastric Carcinoma
Edaise M. Silva, José Humberto, T.G. Fregnani, Sueli Nonogaki, Ericka Monteiro Santos, Renata A. Coudry, Fernando A. Soares
Hospital do Cancer AC Camargo, São Paulo, Brazil